QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.

Abstract:

:Torsades de pointes is a polymorphic ventricular tachycardia characterized by marked QT prolongation on the electrocardiogram. It can be induced by both antiarrhythmic and nonantiarrhythmic drugs, such as quinidine and erythromycin. No extensive literature documents an interaction between quinidine and erythromycin when the agents are administered orally. A 95-year-old man received oral quinidine and erythromycin for the treatment of atrial fibrillation and community-acquired pneumonia. He developed torsades de pointes and subsequently cardiac arrest. Since erythromycin and quinidine are known to cause arrhythmias individually, caution and close monitoring are necessary when the drugs are administered concomitantly.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Lin JC,Quasny HA

subject

Has Abstract

pub_date

1997-05-01 00:00:00

pages

626-30

issue

3

eissn

0277-0008

issn

1875-9114

journal_volume

17

pub_type

杂志文章
  • Salary survey of ambulatory care clinical pharmacists.

    abstract::To determine salary and selected fringe benefits of members of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy, we developed a self-administered questionnaire that surveyed demographic information, schooling and training, academic appointments, yearly salary (as of Februa...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Anastasio GD,Shaughnessy AF

    更新日期:1997-05-01 00:00:00

  • Simvastatin-associated memory loss.

    abstract::The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.7.767.34577

    authors: Orsi A,Sherman O,Woldeselassie Z

    更新日期:2001-06-01 00:00:00

  • Rituximab for the treatment of rheumatoid arthritis.

    abstract::Rituximab has been approved by the United States Food and Drug Administration in combination with methotrexate for the treatment of rheumatoid arthritis in patients who failed to achieve adequate benefit from tumor necrosis factor-alpha inhibitors. Rituximab is a biologic agent that depletes peripheral B cells--an act...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.27.12.1702

    authors: Schuna AA

    更新日期:2007-12-01 00:00:00

  • The pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid arthritis.

    abstract:STUDY OBJECTIVE:To describe the pharmacokinetics and pharmacodynamics of fludarabine in patients with rheumatoid arthritis (RA). DESIGN:Open-label, staggered trial conducted in conjunction with a phase I-II clinical trial. SETTING:Government research hospital. PATIENTS:Twenty-six patients with refractory RA. INTERV...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Knebel W,Davis JC Jr,Sanders WD,Fessler B,Yarboro C,Pucino F,Boumpas DT

    更新日期:1998-11-01 00:00:00

  • A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.

    abstract:STUDY OBJECTIVE:A safe alternative to erythropoiesis-stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by testing the noninfer...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1729

    authors: Birgegård G,Henry D,Glaspy J,Chopra R,Thomsen LL,Auerbach M

    更新日期:2016-04-01 00:00:00

  • Enteric diseases of homosexual men.

    abstract::Certain enteric ailments are particularly common among homosexual men. They are primarily infectious diseases and include not only such common venereal diseases as gonorrhea and syphilis but also infections not usually regarded as being sexually transmitted. Among the latter are shigellosis, salmonellosis, giardiasis,...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03170.x

    authors: Baker RW,Peppercorn MA

    更新日期:1982-01-01 00:00:00

  • Appropriateness of iron prescribing: a retrospective study.

    abstract::We retrospectively reviewed the charts of 120 patients who received an initial prescription of iron from a resident physician in internal medicine to determine how accurately house officers diagnose iron-deficiency anemia before initiating iron therapy. Each patient's laboratory records were reviewed for the 3-month p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Abernathy KA,Meuleman JR

    更新日期:1996-05-01 00:00:00

  • Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System.

    abstract:STUDY OBJECTIVE:Lack of blood pressure control is often seen in hypertensive patients concomitantly taking antituberculosis medications due to the complex drug-drug interactions between rifampin and antihypertensive drugs. Therefore, it is of clinical importance to understand the underlying mechanisms of these interact...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2380

    authors: Liu W,Yan T,Chen K,Yang L,Benet LZ,Zhai S

    更新日期:2020-04-01 00:00:00

  • Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes.

    abstract:STUDY OBJECTIVE:To determine the effect of Niaspan--a niacin preparation with both immediate- and extended-release characteristics--on lipid and glycemic control in patients with type 2 diabetes. DESIGN:Retrospective study SETTING:Private-practice endocrinology group. PATIENTS:Thirty-two patients (mean age 60 yrs; 7...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.20.1473.34481

    authors: Kane MP,Hamilton RA,Addesse E,Busch RS,Bakst G

    更新日期:2001-12-01 00:00:00

  • Complementary and alternative medicine use among individuals participating in research: implications for research and practice.

    abstract:STUDY OBJECTIVES:To determine the frequency and type of complementary and alternative medicine (CAM) use among healthy volunteers participating in research, and to investigate the potential for interactions between commonly used CAM modalities and various drugs. DESIGN:Prospective evaluation. SETTING:University gener...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.12.1794

    authors: Welder GJ,Wessel TR,Arant CB,Schofield RS,Zineh I

    更新日期:2006-12-01 00:00:00

  • Making progress in the management of postoperative pain: a review of the cyclooxygenase 2-specific inhibitors.

    abstract::Postoperative pain is one of the most common forms of acute pain. Optimal pain management decreases the stress response to surgery, reduces complications, improves recovery time, and results in improved economic and quality-of-life outcomes. A preoperative, multimodal approach to postoperative analgesia can be achieve...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.17.1714.52339

    authors: Stephens JM,Pashos CL,Haider S,Wong JM

    更新日期:2004-12-01 00:00:00

  • Introduction to immunology.

    abstract::The immune system is a complex network of components functioning to provide host defense. This network consists of immunologic cells and their products (e.g., interleukins and colony-stimulating factors), organs, tissues, complement, and major histocompatibility complex antigens. These components are organized into sp...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McIntyre WJ,Tami JA

    更新日期:1992-01-01 00:00:00

  • Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics.

    abstract::Verapamil hydrochloride, a prototype calcium antagonist, is now marketed in the United States for the acute treatment of supraventricular tachyarrhythmias and for chronic management of vasospastic and chronic stable angina. It inhibits the slow inward channel in in the heart and blocks calcium influx in smooth muscle....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03210.x

    authors: Baky SH,Singh BN

    更新日期:1982-11-01 00:00:00

  • Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.

    abstract::Methotrexate, administered for treatment of pediatric and adult malignancies, is a direct renal toxin, which can lead to renal dysfunction, decreased methotrexate clearance, elevated methotrexate concentrations, and systemic toxicity. Although plasma methotrexate concentrations have been shown to decline precipitously...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.30.1.111

    authors: Vilay AM,Mueller BA,Haines H,Alten JA,Askenazi DJ

    更新日期:2010-01-01 00:00:00

  • Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.

    abstract:STUDY OBJECTIVE:To evaluate the microbiologic and clinical outcomes of patients with extended-spectrum beta-lactamase (ESBL)-producing isolates over a 2-year period. DESIGN:Retrospective analysis. SETTING:Tertiary care teaching hospital. PATIENTS:Twenty-one patients with cultures of confirmed ESBL-producing Escheric...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.12.1232.32706

    authors: Burgess DS,Hall RG 2nd,Lewis JS 2nd,Jorgensen JH,Patterson JE

    更新日期:2003-10-01 00:00:00

  • Torsades de pointes associated with fluoroquinolones.

    abstract::Recent attention has been called to the interpretation of studies of antiinfective agents demonstrating effects on the QTc interval. It seems that the effects of many of these agents on the QTc interval are small, but in some patient populations, these drugs may cause morbidity and mortality related to TdP. It would b...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.22.8.663.33201

    authors: Owens RC Jr,Ambrose PG

    更新日期:2002-05-01 00:00:00

  • A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities.

    abstract::A major factor in delivering patient care is documenting activities by pharmacists. This documentation is not only essential to sustain existing programs but necessary to justify future growth of resources. A computerized documentation system for clinical interventions and workload activities was developed in a 340-be...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Zimmerman CR,Smolarek RT,Stevenson JG

    更新日期:1995-03-01 00:00:00

  • Do Electronic Cigarettes Have a Role in Tobacco Cessation?

    abstract::Tobacco use continues to be a major cause of morbidity and mortality. Even with behavioral and pharmacologic treatment, long-term tobacco cessation rates are low. Electronic nicotine delivery systems, commonly referred to as electronic cigarettes or e-cigarettes, are increasingly used for tobacco cessation. Because e-...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2103

    authors: Franks AS,Sando K,McBane S

    更新日期:2018-05-01 00:00:00

  • Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.

    abstract::An area of unidirectional conduction block is one requirement for reentrant arrhythmias to occur. Functional block caused by dispersion of repolarization and refractoriness is the most probable mechanism of drug-induced unidirectional conduction block. We assessed the effects of lidocaine on spatial dispersion of myoc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Sims JJ,Winecoff AP,Ujhelyi MR

    更新日期:1997-11-01 00:00:00

  • Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.

    abstract:BACKGROUND:Historically, there is perceived pressure to achieve therapeutic levels of tacrolimus quickly after heart transplant (HT). We evaluated the association between time within therapeutic tacrolimus range and time to therapeutic trough and rejection in the 30 days following HT. METHODS:This is a single-center r...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2262

    authors: Baker WL,Steiger S,Martin S,Patel N,Radojevic J,Darsaklis K,O'Bara L,Kutzler H,Dougherty J,Feingold A,Hammond J,Fusco D,Gluck JA

    更新日期:2019-05-01 00:00:00

  • Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin.

    abstract::Dabigatran, a direct thrombin inhibitor, is an oral anticoagulant indicated for the prevention of stroke in patients with atrial fibrillation (AF) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. Dabigatran, as well as the other new anticoagulants-rivaroxaban, apixaban, and edoxaban...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1698

    authors: Wiggins BS,Northup A,Johnson D,Senfield J

    更新日期:2016-02-01 00:00:00

  • Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?

    abstract::Verapamil and diltiazem are effective in terminating paroxysmal supraventricular tachycardias and slowing ventricular response during atrial fibrillation or flutter. Results from clinical trials for each individual drug demonstrate comparative efficacy rates, and both drugs share the same contraindications and relativ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Cheiman DM,Shea BF,Kelly RA

    更新日期:1996-09-01 00:00:00

  • Piperacillin-Tazobactam: a new beta-lactam-beta-lactamase inhibitor combination.

    abstract::We reviewed the spectrum of activity, pharmacokinetics, clinical efficacy, adverse effects, and relative advantages of piperacillin-tazobactam, a new beta-lactam-beta-lactamase inhibitor. Piperacillin-tazobactam has a wide spectrum of activity that includes gram-positive organisms such as staphylococci and streptococc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Daniel KP,Krop LC

    更新日期:1996-03-01 00:00:00

  • Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy.

    abstract::Among various forms of hearing loss, there are acute (within 72 hrs) or subacute (weeks to months) presentations that may be reversible with early pharmacological intervention. The workup of a patient presenting with hypoacusia includes the usual history and physical examination in conjunction with an audiometric asse...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2044

    authors: Fazel MT,Jedlowski PM,Cravens RB Jr,Erstad BL

    更新日期:2017-12-01 00:00:00

  • Oxandrolone treatment in adults with severe thermal injury.

    abstract::Severe thermal injury is associated with hypermetabolism and hypercatabolism, leading to skeletal muscle breakdown, lean body mass loss, weight loss, and negative nitrogen balance. Muscle protein catabolism in patients with severe thermal injury is the result of stress-induced increased release of cytokines and counte...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.2.213

    authors: Miller JT,Btaiche IF

    更新日期:2009-02-01 00:00:00

  • Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.

    abstract:STUDY OBJECTIVES:To evaluate the efficacy of a single, low-dose injection of botulinum toxin type A in relieving pain in Korean patients with piriformis syndrome resistant to conventional therapy, and to assess the drug's influence on these patients' quality of life. DESIGN:Prospective, single-site, open-label trial. ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.5.657

    authors: Yoon SJ,Ho J,Kang HY,Lee SH,Kim KI,Shin WG,Oh JM

    更新日期:2007-05-01 00:00:00

  • Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years.

    abstract:OBJECTIVE:To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). METHODS:A search of the primary literature was conducted by using MEDLINE, the National Institutes of Health medical research Web site (www.clinicaltrials.gov), and the United States Food and Drug Administration's Ce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2006.26.1.68

    authors: Hackman AM,Lackner TE

    更新日期:2006-01-01 00:00:00

  • Itraconazole and fluconazole and certain rare, serious adverse events.

    abstract:STUDY OBJECTIVE:To determine rates of drug-induced, rare, serious adverse events affecting the liver, kidneys, skin, or blood, occurring within 45 days of completing a prescription or refill for itraconazole or fluconazole. DESIGN:Population-based follow-up study SETTING:United Kingdom-based General Practice Research...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.9.697.34072

    authors: Bradbury BD,Jick SS

    更新日期:2002-06-01 00:00:00

  • Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls.

    abstract:STUDY OBJECTIVE:To evaluate the relationship between impaired renal function and antifactor Xa activity in patients receiving dalteparin. DESIGN:Open-label prospective study. SETTING:Inpatient and outpatient units of a large teaching hospital. SUBJECTS:Eleven patients with renal impairment and 11 control subjects wi...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.2005.25.6.817

    authors: Shprecher AR,Cheng-Lai A,Madsen EM,Cohen HW,Sinnett MJ,Wong ST,Billett HH

    更新日期:2005-06-01 00:00:00

  • The effect of Cys LT1 receptor blockade on airway responses to allergen.

    abstract:STUDY OBJECTIVE:To evaluate the effect of a potent experimental leukotriene receptor antagonist, MK-571, on airway responses to inhaled allergen. DESIGN:Randomized, double-blind, placebo-controlled, crossover trial. SETTING:Clinical research center. SUBJECTS:Eight male volunteers with allergic asthma. INTERVENTIONS...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.19.16.1243.30878

    authors: Hendeles L,Davison D,Harman E,Sherman JM

    更新日期:1999-11-01 00:00:00